Price : USD 149000.00 ~~298000.00~~

Quantity:

https://wa.me/message/NKQQAJRJTBKCF1

Description:

Lumizyme replaces a missing or deficient enzyme in people with Pompe disease, a genetic disorder caused by the buildup of a sugar called glycogen in the body's cells. The drug is marketed by French drugmaker Sanofi (NASDAQ:SNY) and costs more than $626000 annually.

Pompe disease is estimated to occur in one out of every 40,000 live births. However, the frequency in the African-American population is higher, at roughly one in 14,000 births. Sanofi obtained approval for an earlier Pompe disease treatment called Myozyme in 2006. However, when the company scaled up the bioreactor that produced Myozyme, the FDA required a separate approval process. This led to Lumizyme's approval and launch in 2010.

Terms & conditions:

Safety and Abuse Reporting

Harassment and Cyberbullying

Impersonation

Violent Threats

Hate Speech Against a Protected Group

Spam and Scams

None of these are my issue

Thanks for being awesome!

We appreciate you contacting us. Our support will get back in touch with you soon!

Have a great day!

Are you sure you want to report abuse against this website?

Please note that your query will be processed only if we find it relevant. Rest all requests will be ignored. If you need help with the website, please login to your dashboard and connect to support

Description:

Terms & conditions:

bathshot

denolden

Humatrope lilly 12mg 63Iu

oxandrolone tablets 100×10mg

Extenze

NICK TRIGILI GYM

Select a date and time slot to book an Appointment

Safety and Abuse Reporting

Thanks for being awesome!

Are you sure you want to report abuse against this website?

lumizyme

Description:

Terms & conditions:

Share Via:

Related Products

bathshot

denolden

Humatrope lilly 12mg 63Iu

oxandrolone tablets 100×10mg

Extenze

Subscribe to our newsletter and stay in touch

Safety and Abuse Reporting

Thanks for being awesome!

Are you sure you want to report abuse against this website?